Advertisement
Review Article| Volume 6, ISSUE 1, P151-165, May 2023

Download started.

Ok

Acne Treatment Strategies 2023

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Cosmetic Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Gan S.D.
        • Graber E.M.
        Papular scars: an addition to the acne scar classification scheme.
        J Clin Aesthet Dermatol. 2015; 8: 19-20
        • Gollnick H.P.
        • Finlay A.Y.
        • Shear N.
        Global Alliance to Improve Outcomes in Acne. Can we define acne as a chronic disease? If so, how and when?.
        Am J Clin Dermatol. 2008; 9: 279-284
        • Fox L.
        • Csongradi C.
        • Aucamp M.
        • et al.
        Treatment Modalities for Acne.
        Molecules. 2016; 21: 1063
        • Decker A.
        • Graber E.M.
        Over-the-counter Acne Treatments: A Review.
        J Clin Aesthet Dermatol. 2012; 5: 32-40
        • Layton A.M.
        Top Ten List of Clinical Pearls in the Treatment of Acne Vulgaris.
        Dermatol Clin. 2016; 34: 147-157
        • Eichenfield D.Z.
        • Sprague J.
        • Eichenfield L.F.
        Management of Acne Vulgaris: A Review.
        JAMA. 2021; 326: 2055-2067
        • Dréno B.
        Treatment of adult female acne: a new challenge.
        J Eur Acad Dermatol Venereol. 2015; 29: 14-19
        • Schmidt N.
        • Gans E.H.
        Tretinoin: A Review of Its Anti-inflammatory Properties in the Treatment of Acne.
        J Clin Aesthet Dermatol. 2011; 4: 22-29
        • Kang S.
        The mechanism of action of topical retinoids.
        Cutis. 2005; 75: 10-13
        • Miller L.S.
        Toll-like receptors in skin.
        Adv Dermatol. 2008; 24: 71-87
        • Motamedi M.
        • Chehade A.
        • Sanghera R.
        • et al.
        A Clinician's Guide to Topical Retinoids.
        J Cutan Med Surg. 2022; 26: 71-78
        • Quigley J.W.
        • Bucks D.A.
        Reduced skin irritation with tretinoin containing polyolprepolymer-2, a new topical tretinoin delivery system: a summary of preclinical and clinical investigations.
        J Am Acad Dermatol. 1998; 38: S5-S10
        • Rosso J.D.
        • Harper J.
        • Pillai R.
        • et al.
        Tretinoin photostability: comparison of micronized tretinoin gel 0.05% and tretinoin gel 0.025% following exposure to fluorescent and solar light.
        J Clin Aesthet Dermatol. 2013; 6: 25-28
        • Dubina M.I.
        • Fleischer Jr., A.B.
        Interaction of topical sulfacetamide and topical dapsone with benzoyl peroxide.
        Arch Dermatol. 2009; 145: 1027-1029
        • Duell E.A.
        • Kang S.
        • Voorhees J.J.
        Unoccluded retinol penetrates human skin in vivo more effectively than unoccluded retinyl palmitate or retinoic acid.
        J Invest Dermatol. 1997; 109: 301-305
        • Kang S.
        • Leyden J.J.
        • Lowe N.J.
        • et al.
        Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks.
        Arch Dermatol. 2001; 137: 1597-1604
        • Cunliffe W.J.
        • Poncet M.
        • Loesche C.
        • et al.
        A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials.
        Br J Dermatol. 1998; 139: 48-56
        • Zaenglein A.L.
        • Pathy A.L.
        • Schlosser B.J.
        • et al.
        Guidelines of care for the management of acne vulgaris.
        J Am Acad Dermatol. 2016; 74 ([published correction appears in J Am Acad Dermatol 2020;82(6):1576]): 945-973.e33
        • Kakita L.
        Tazarotene versus tretinoin or adapalene in the treatment of acne vulgaris.
        J Am Acad Dermatol. 2000; 43: S51-S54
        • Kircik L.H.
        • Gold L.S.
        • Beer K.
        • et al.
        Once-Daily Polymeric Tazarotene 0.045% Lotion for Moderate-to-Severe Acne: Pooled Phase 3 Analysis by Sex.
        J Drugs Dermatol. 2020; 19: 777-783
        • Baldwin H.
        • Webster G.
        • Stein Gold L.
        • et al.
        50 Years of Topical Retinoids for Acne: Evolution of Treatment.
        Am J Clin Dermatol. 2021; 22: 315-327
        • Leyden J.J.
        Efficacy of benzoyl peroxide (5.3%) emollient foam and benzoyl peroxide (8%) wash in reducing Propionibacterium acnes on the back.
        J Drugs Dermatol. 2010; 9: 622-625
        • Tanghetti E.A.
        • Popp K.F.
        A current review of topical benzoyl peroxide: new perspectives on formulation and utilization.
        Dermatol Clin. 2009; 27: 17-24
        • Leyden J.J.
        • Mitchell W.
        • Baldwin E.K.
        Antibiotic-resistant Propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6%.
        Cutis. 2008; 82: 417-421
        • Mills Jr., O.H.
        • Kligman A.M.
        • Pochi P.
        • et al.
        Comparing 2.5%, 5%, and 10% benzoyl peroxide on inflammatory acne vulgaris.
        Int J Dermatol. 1986; 25: 664-667
        • Worret W.I.
        • Fluhr J.W.
        Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid.
        JDDG J der Deutschen Dermatol Gesellschaft. 2006; 4: 293-300
        • Alkhawaja E.
        • Hammadi S.
        • Abdelmalek M.
        • et al.
        Antibiotic resistant Cutibacterium acnes among acne patients in Jordan: a cross sectional study.
        BMC Dermatol. 2020; 20: 17
      1. S. Crm, ACNE ROSACEA. t. The APRN’s Complete Guide to Prescribing, Drug Ther 3 (2017) (2018) 5–8.

        • Leyden J.J.
        • Berger R.S.
        • Dunlap F.E.
        • et al.
        Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the treatments of acne vulgaris.
        Am J Clin Dermatol. 2001; 2: 33-39
        • Ghaoui N.
        • Hanna E.
        • Abbas O.
        • et al.
        Update on the use of dapsone in dermatology.
        Int J Dermatol. 2020; 59: 787-795
        • Webster G.F.
        Is topical dapsone safe in glucose-6-phosphate dehydrogenase-deficient and sulfonamide-allergic patients?.
        J Drugs Dermatol. 2010; 9: 532-536
        • Hebert A.
        • Thiboutot D.
        • Stein Gold L.
        • et al.
        Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne: Two Phase 3 Randomized Clinical Trials.
        JAMA Dermatol. 2020; 156: 621-630
        • Sanchez C.
        • Keri J.
        Androgen Receptor Inhibitors in the Treatment of Acne Vulgaris: Efficacy and Safety Profiles of Clascoterone 1% Cream.
        Clin Cosmet Investig Dermatol. 2022; 15: 1357-1366
        • Gollnick H.
        • Schramm M.
        Topical therapy in acne.
        J Eur Acad Dermatol Venereol. 1998; 11: S8-S29
        • Del Rosso J.Q.
        Azelaic Acid Topical Formulations: Differentiation of 15% Gel and 15% Foam.
        J Clin Aesthet Dermatol. 2017; 10: 37-40
        • Callender V.D.
        • St Surin-Lord S.
        • Davis E.C.
        • et al.
        Postinflammatory hyperpigmentation: etiologic and therapeutic considerations.
        Am J Clin Dermatol. 2011; 12: 87-99
        • Gupta A.K.
        • Gover M.D.
        Azelaic acid (15% gel) in the treatment of acne rosacea.
        Int J Dermatol. 2007; 46: 533-538
        • Bayerl C.
        Acne therapy in pregnancy.
        Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 2013; 64: 269-273
        • Arif T.
        Salicylic acid as a peeling agent: a comprehensive review.
        Clin Cosmet Investig Dermatol. 2015; 8: 455-461
        • Zander E.
        • Weisman S.
        Treatment of acne vulgaris with salicylic acid pads.
        Clin Ther. 1992; 14: 247-253
        • Nast A.
        • Dréno B.
        • Bettoli V.
        • et al.
        European evidence-based (S3) guidelines for the treatment of acne.
        J Eur Acad Dermatol Venereol. 2012; 26: 1-29
        • Graber E.
        Treating acne with the tetracycline class of antibiotics: A review.
        Dermatological Reviews. 2021; 2: 321-330
        • George S.
        • Muhaj F.F.
        • Nguyen C.D.
        • et al.
        Part I Antimicrobial resistance: Bacterial pathogens of dermatologic significance and implications of rising resistance.
        J Am Acad Dermatol. 2022; 86: 1189-1204
        • Swallow M.A.
        • Fan R.
        • Cohen J.
        • et al.
        Antibiotic Resistance Risk with Oral Tetracycline Treatment of Acne Vulgaris.
        Antibiotics. 2022; 11: 1032
        • Dreno B.
        • Thiboutot D.
        • Gollnick H.
        • et al.
        Antibiotic stewardship in dermatology: limiting antibiotic use in acne.
        Eur J Dermatol. 2014; 24: 330-334
        • Del Rosso J.Q.
        Oral Doxycycline in the Management of Acne Vulgaris: Current Perspectives on Clinical Use and Recent Findings with a New Double-scored Small Tablet Formulation.
        J Clin Aesthet Dermatol. 2015; 8: 19-26
        • Skidmore R.
        • Kovach R.
        • Walker C.
        • et al.
        Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne.
        Arch Dermatol. 2003; 139: 459-464
        • Zhanel G.
        • Critchley I.
        • Lin L.Y.
        • et al.
        Microbiological Profile of Sarecycline, a Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris.
        Antimicrob Agents Chemother. 2018; 63: e01297-18
        • Baldwin H.
        Oral Antibiotic Treatment Options for Acne Vulgaris.
        J Clin Aesthet Dermatol. 2020; 13: 26-32
        • Leyden J.J.
        The role of isotretinoin in the treatment of acne: personal observations.
        J Am Acad Dermatol. 1998; 39: S45-S49
        • Ward A.
        • Brogden R.N.
        • Heel R.C.
        • et al.
        Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders.
        Drugs. 1984; 28: 6-37
        • Vallerand I.A.
        • Lewinson R.T.
        • Farris M.S.
        • et al.
        Efficacy and adverse events of oral isotretinoin for acne: a systematic review.
        Br J Dermatol. 2018; 178: 76-85
        • Brelsford M.
        • Beute T.C.
        Preventing and managing the side effects of isotretinoin.
        Semin Cutan Med Surg. 2008; 27: 197-206
        • Spring L.K.
        • Krakowski A.C.
        • Alam M.
        • et al.
        Isotretinoin and Timing of Procedural Interventions: A Systematic Review With Consensus Recommendations.
        JAMA Dermatol. 2017; 153: 802-809
        • Marson J.W.
        • Baldwin H.E.
        Elevated creatine kinase levels, exercise, and isotretinoin for acne.
        JAAD Case Rep. 2022; 21 (Published 2022 Jan 22): 133-135
        • Lee A.G.
        Pseudotumor cerebri after treatment with tetracycline and isotretinoin for acne.
        Cutis. 1995; 55: 165-168
        • Etminan M.
        • Bird S.T.
        • Delaney J.A.
        • et al.
        Isotretinoin and risk for inflammatory bowel disease: a nested case-control study and meta-analysis of published and unpublished data.
        JAMA Dermatol. 2013; 149: 216-220
        • Sood S.
        • Jafferany M.
        • Vinaya Kumar S.
        Depression, psychiatric comorbidities, and psychosocial implications associated with acne vulgaris.
        J Cosmet Dermatol. 2020; 19: 3177-3182
        • Huang Y.C.
        • Cheng Y.C.
        Isotretinoin treatment for acne and risk of depression: A systematic review and meta-analysis [published correction appears in J Am Acad Dermatol. 2017 Nov 14.
        J Am Acad Dermatol. 2017; 76 (e9): 1068-1076
        • Leyden J.J.
        • Del Rosso J.Q.
        • Baum E.W.
        The use of isotretinoin in the treatment of acne vulgaris: clinical considerations and future directions.
        J Clin Aesthet Dermatol. 2014; 7: S3-S21
        • Tran P.T.
        • Berman H.S.
        • Leavitt E.
        • et al.
        Analysis of factors associated with relapse in patients on their second course of isotretinoin for acne vulgaris.
        J Am Acad Dermatol. 2021; 84: 856-859
        • Blasiak R.C.
        • Stamey C.R.
        • Burkhart C.N.
        • et al.
        High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.
        JAMA Dermatol. 2013; 149: 1392-1398
        • Del Rosso J.Q.
        Face to face with oral isotretinoin: a closer look at the spectrum of therapeutic outcomes and why some patients need repeated courses.
        J Clin Aesthet Dermatol. 2012; 5: 17-24
        • Xia E.
        • Han J.
        • Faletsky A.
        • et al.
        Isotretinoin Laboratory Monitoring in Acne Treatment: A Delphi Consensus Study.
        JAMA Dermatol. 2022; 158: 942-948
        • Barbieri J.S.
        • Shin D.B.
        • Wang S.
        • et al.
        The clinical utility of laboratory monitoring during isotretinoin therapy for acne and changes to monitoring practices over time.
        J Am Acad Dermatol. 2020; 82: 72-79
        • Graber E.M.
        K+larity for Spironolactone: At Last.
        JAMA Dermatol. 2015; 151: 926-927
        • Roberts E.E.
        • Nowsheen S.
        • Davis M.D.P.
        • et al.
        Treatment of acne with spironolactone: a retrospective review of 395 adult patients at Mayo Clinic, 2007-2017.
        J Eur Acad Dermatol Venereol. 2020; 34: 2106-2110
        • Wei C.
        • Bovonratwet P.
        • Gu A.
        • et al.
        Spironolactone use does not increase the risk of female breast cancer recurrence: A retrospective analysis.
        J Am Acad Dermatol. 2020; 83: 1021-1027
        • Thiede R.M.
        • Rastogi S.
        • Nardone B.
        • et al.
        Hyperkalemia in women with acne exposed to oral spironolactone: A retrospective study from the RADAR (Research on Adverse Drug Events and Reports) program.
        Int J Womens Dermatol. 2019; 5: 155-157
        • George R.
        • Clarke S.
        • Thiboutot D.
        Hormonal therapy for acne.
        Semin Cutan Med Surg. 2008; 27: 188-196
        • Mohsin N.
        • Hernandez L.E.
        • Martin M.R.
        • et al.
        Acne treatment review and future perspectives [published online ahead of print, 2022 Jul 16].
        Dermatol Ther. 2022; : e15719https://doi.org/10.1111/dth.15719
        • Rapkin A.J.
        • Winer S.A.
        Drospirenone: a novel progestin.
        Expert Opin Pharmacother. 2007; 8: 989-999
        • Mazori D.R.
        The ABCs of COCs: a guide for dermatology residents on combined oral contraceptives.
        Cutis. 2019; 104: E10-E14
        • Oray M.
        • Abu Samra K.
        • Ebrahimiadib N.
        • et al.
        Long-term side effects of glucocorticoids.
        Expert Opin Drug Saf. 2016; 15: 457-465
        • Bachelot A.
        • Chakthoura Z.
        • Rouxel A.
        • et al.
        Classical forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in adults.
        Horm Res. 2008; 69: 203-211
      2. E. Graber, Acne surgery. Krakowski, Andrew C. Procedural Pediatric Dermatology, Lippincott Williams & Wilkins, Philadelphia, PA, 2020.

        • Kesty K.
        • Goldberg D.J.
        650 usec 1064nm Nd:YAG laser treatment of acne: A double-blind randomized control study.
        J Cosmet Dermatol. 2020; 19: 2295-2300
        • Sakamoto F.H.
        • Doukas A.G.
        • Farinelli W.A.
        • et al.
        Selective photothermolysis to target sebaceous glands: theoretical estimation of parameters and preliminary results using a free electron laser.
        Lasers Surg Med. 2012; 44: 175-183
      3. Data on file. FDA clearance study. Cutera Inc.

        • Paithankar D.
        • Hwang B.H.
        • Munavalli G.
        • et al.
        Ultrasonic delivery of silica-gold nanoshells for photothermolysis of sebaceous glands in humans: Nanotechnology from the bench to clinic.
        J Contra Release. 2015; 206: 30-36
        • Wanitphakdeedecha R.
        • Tanzi E.L.
        • Alster T.S.
        Photopneumatic therapy for the treatment of acne.
        J Drugs Dermatol. 2009; 8: 239-241
        • Bae-Harboe Y.S.
        • Graber E.M.
        Easy as PIE (Postinflammatory Erythema).
        J Clin Aesthet Dermatol. 2013; 6: 46-47
        • Ibrahim S.M.
        • Farag A.
        • Hegazy R.
        • et al.
        Combined Low-Dose Isotretinoin and Pulsed Dye Laser Versus standard-Dose Isotretinoin in the Treatment of Inflammatory Acne.
        Lasers Surg Med. 2021; 53: 603-609
      4. Trifarotene (Aklief)-A New Topical Retinoid for Acne.
        JAMA. 2020; 323: 1310-1311